HomeADIL • NASDAQ
add
Adial Pharmaceuticals Inc
Previous close
$1.03
Day range
$0.99 - $1.04
Year range
$0.78 - $4.17
Market cap
6.53M USD
Avg Volume
128.12K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 2.29M | 54.82% |
Net income | -2.46M | -325.99% |
Net profit margin | — | — |
Earnings per share | -0.59 | 55.64% |
EBITDA | -2.29M | -54.82% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 3.29M | 169.91% |
Total assets | 4.95M | 30.95% |
Total liabilities | 671.88K | 45.51% |
Total equity | 4.28M | — |
Shares outstanding | 6.40M | — |
Price to book | 1.03 | — |
Return on assets | -98.31% | — |
Return on capital | -109.98% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | -2.46M | -325.99% |
Cash from operations | -2.15M | -13.39% |
Cash from investing | — | — |
Cash from financing | 411.09K | 708,677.59% |
Net change in cash | -1.74M | -58.72% |
Free cash flow | -1.34M | 18.16% |
About
Founded
2010
Headquarters
Website
Employees
6
